Cargando…

Rare Mutations in Cancer Drug Resistance and Implications for Therapy

Detalles Bibliográficos
Autores principales:	Beckman, Robert A., Loeb, Lawrence A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484911/ https://www.ncbi.nlm.nih.gov/pubmed/32648584 http://dx.doi.org/10.1002/cpt.1938

Ejemplares similares

Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care
por: Tu, Shi-Ming, et al.
Publicado: (2022)

Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
por: Husain, Aliabbas A., et al.
Publicado: (2021)

Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy
por: Zargar, Amin, et al.
Publicado: (2020)

Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer
por: Fox, Edward J., et al.
Publicado: (2016)

New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs
por: Beckman, Robert A., et al.
Publicado: (2013)

Negotiating prices of drugs for rare diseases
por: Henrard, Séverine, et al.
Publicado: (2016)

Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance
por: Huang, Laurence, et al.
Publicado: (2004)

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
por: Blanco, Jose-Luis, et al.
Publicado: (2011)

Drug-resistant Neisseria gonorrhoeae in Michigan
por: Macomber, Kathryn E., et al.
Publicado: (2005)

HIV Drug-resistant Strains as Epidemiologic Sentinels
por: Sánchez, María S., et al.
Publicado: (2006)

Epigenetic mechanisms in breast cancer therapy and resistance
por: Garcia-Martinez, Liliana, et al.
Publicado: (2021)

Drugs Against Rare Diseases: Are The Regulatory Standards Higher?
por: Gobburu, J, et al.
Publicado: (2016)

The economics of moonshots: Value in rare disease drug development
por: Yates, Nathan, et al.
Publicado: (2022)

Addressing Drug Resistance in Cancer: A Team Medicine Approach
por: Kulkarni, Prakash, et al.
Publicado: (2022)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
por: Bennett, David A.
Publicado: (2017)

Bioenergy and its Implication for Yoga Therapy
por: Narayanan, Chathapuram Rajan, et al.
Publicado: (2018)

From fuzziness to precision medicine: on the rapidly evolving proteomics with implications in mitochondrial connectivity to rare human disease
por: Aly, Khaled A., et al.
Publicado: (2021)

Why Is the Biodegradation of Polyfluorinated Compounds So Rare?
por: Wackett, Lawrence P.
Publicado: (2021)

Origin and interpretation of cancer transcriptome profiling: the essential role of the stroma in determining prognosis and drug resistance
por: Goossens, Nicolas, et al.
Publicado: (2015)

Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy
por: Inoue, Akira, et al.
Publicado: (2005)

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020)

Mitochondrial DNA Mutations in Cancer
por: Zanssen, Stefanie, et al.
Publicado: (2005)

Mesenchymal stem cells, implications for pain therapy
por: Trallori, Elena, et al.
Publicado: (2019)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
por: Fan, Yuanyuan, et al.
Publicado: (2022)

Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections
por: Kowalski, Regis P., et al.
Publicado: (2022)

Mapping the Spread of Malaria Drug Resistance
por: Anderson, Tim
Publicado: (2009)

Extensive Drug Resistance in Malaria and Tuberculosis
por: Wongsrichanalai, Chansuda, et al.
Publicado: (2010)

An Emptying Quiver: Antimicrobial Drugs and Resistance
por: Weber, J. Todd, et al.
Publicado: (2005)

Antimicrobial Drug Resistance, Regulation, and Research
por: Metlay, Joshua P., et al.
Publicado: (2006)

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
por: Lappin, Katrina M., et al.
Publicado: (2021)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
por: Rudzińska, Magdalena, et al.
Publicado: (2021)

Decision Challenges for Managing Acute Paediatric Infections: Implications for Antimicrobial Resistance
por: Krockow, Eva M., et al.
Publicado: (2023)

Population Mobility, Globalization, and Antimicrobial Drug Resistance
por: MacPherson, Douglas W., et al.
Publicado: (2009)

Perspective on model‐informed drug development
por: Lesko, Lawrence J.
Publicado: (2021)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

Making Every Subject Count: A Case Study of Drug Development Path for Medication in a Pediatric Rare Disease
por: Bhattacharya, I, et al.
Publicado: (2016)

Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm
por: Zykov, Kirill A, et al.
Publicado: (2017)

Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
por: Stratton, Charles W.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_hl3ntfpm52vtrsu3a0po0gpm27